abstract |
A method for the treatment of a host, and in particular, a human, infected with hepatitis B virus (HBV) is provided that includes administering an effective amount of a nucleotide prodrug of beta- L-2', 3'-dideoxyadenosine, wherein the prodrug component of the nucleotide provides controlled delivery of the active species. |